Skip to content
★ Sign in to follow
LE

Lawrence E. Bullock

CFO
Applied Genetic Technologies CorpBiomimetic Therapeutics, Inc.
Total declarations
24
Companies
2
▲ Purchases (11 ops.)
€261k
▼ Sales (0 ops.)
—

Latest filing published 20 Sept 2016 for Applied Genetic Technologies CORP, €78k.

Insider track record

Disclosed buys
11
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
11

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Lawrence E. Bullock: trading record in brief

Filings by Lawrence E. Bullock span 2 companies, the busiest being Biomimetic Therapeutics, Inc. and Applied Genetic Technologies Corp. The record holds 24 filings, for trades running from 12 May 2006 to 19 September 2016.

No open-market sale appears; the market trades are 11 purchases worth €261k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. Since January 2016: 1 purchase and no sales on the market.

Half of the purchases are above €3,890 and half below.

On 20 September 2016 came the latest disclosure, an open-market purchase for €78k in Applied Genetic Technologies Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Lawrence E. Bullock

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations